Cumberland Pharmaceuticals, Inc. (CPIX): CPIX declined from its initial pricing o...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	40
Posts	7682
Boards Moderated	1
Alias Born	01/04/2006

mlkrborn

Re: surf1944 post# 2

Tuesday, 08/17/2010 2:21:54 PM

Tuesday, August 17, 2010 2:21:54 PM

CPIX declined from its initial pricing of $17 to $6.00! Is this a buy level?
tia
GL

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CPIX News

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS • PR Newswire (US) • 04/30/2024 08:05:00 PM
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS • PR Newswire (US) • 04/02/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:10:30 PM
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results • PR Newswire (US) • 03/05/2024 09:05:00 PM
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS • PR Newswire (US) • 02/27/2024 09:05:00 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 10:27:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:11:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:10:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:08:24 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/27/2023 05:15:30 AM
Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/15/2023 09:14:42 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/14/2023 10:09:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 10:05:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 10:04:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 10:03:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 10:02:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:21:37 PM
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/07/2023 09:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:05:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:05:04 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:02:00 PM
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS • PR Newswire (US) • 10/31/2023 08:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2023 09:04:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 01:11:16 PM

More CPIX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover